Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1.24B
-
Number of holders
-
1634
-
Total 13F shares, excl. options
-
998M
-
Shares change
-
-18.3M
-
Total reported value, excl. options
-
$74.6B
-
Value change
-
-$1.15B
-
Put/Call ratio
-
0.83
-
Number of buys
-
852
-
Number of sells
-
-761
-
Price
-
$74.76
Significant Holders of GILEAD SCIENCES, INC. - Common Stock (GILD) as of Q1 2020
1,857 filings reported holding GILD - GILEAD SCIENCES, INC. - Common Stock as of Q1 2020.
GILEAD SCIENCES, INC. - Common Stock (GILD) has 1,634 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 998M shares
of 1.24B outstanding shares and own 80.4% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (107M shares), BlackRock Inc. (101M shares), Capital Research Global Investors (96M shares), STATE STREET CORP (56.8M shares), Capital International Investors (56.4M shares), Capital World Investors (46.3M shares), GEODE CAPITAL MANAGEMENT, LLC (19.9M shares), Bank of New York Mellon Corp (18.9M shares), NORTHERN TRUST CORP (15.6M shares), and Dodge & Cox (15.1M shares).
This table shows the top 1634 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.